Search Results - "Dall’Olio, Filippo G."

ECOG performance status ≥2 as a prognostic factor in patients with advanced non small cell lung cancer treated with immune checkpoint inhibitors—A systematic review and meta-analysis of real world data by Dall’Olio, Filippo G., Maggio, Ilaria, Massucci, Maria, Mollica, Veronica, Fragomeno, Benedetta, Ardizzoni, Andrea

“…•Immune Checkpoint Inhibitors (ICI) are used regardless of performance status.•Randomized clinical trials (RCT) of ICIs enrolled mostly patients with ECOG PS 0…”
Get full text

Immortal Time Bias Question in the Association Between Toxicity and Outcome of Immune Checkpoint Inhibitors by Dall'Olio, Filippo G, Di Nunno, Vincenzo, Massari, Francesco

Get full text

Overcoming Primary Resistance to PD-1 Inhibitor With Anti–PD-L1 Agent in Squamous-Cell NSCLC: Case Report by Gelsomino, Francesco, Di Federico, Alessandro, Filippini, Daria M., Dall’Olio, Filippo G., Lamberti, Giuseppe, Sperandi, Francesca, Balacchi, Caterina, Brocchi, Stefano, Ardizzoni, Andrea

Get full text

Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations by Cortellini, Alessio, Ricciuti, Biagio, Vaz, Victor R, Soldato, Davide, Alessi, Joao V, Dall’Olio, Filippo G, Banna, Giuseppe L, Muthuramalingam, Sethupathi, Chan, Samuel, Majem, Margarita, Piedra, Aida, Lamberti, Giuseppe, Andrini, Elisa, Addeo, Alfredo, Friedlaender, Alex, Facchinetti, Francesco, Gorría, Teresa, Mezquita, Laura, Hoton, Delphine, Valerie, Lacroix, Nana, Frank Aboubakar, Artingstall, James, Comins, Charles, Di Maio, Massimo, Caglio, Andrea, Cave, Judith, McKenzie, Hayley, Newsom-Davis, Thomas, Evans, Joanne S, Tiseo, Marcello, D'Alessio, Antonio, Fulgenzi, Claudia A M, Besse, Benjamin, Awad, Mark M, Pinato, David J

“…IntroductionIt has been recognized that increasing body mass index (BMI) is associated with improved outcome from immune checkpoint inhibitors (ICIs) in…”
Get full text

Tumour burden and efficacy of immune-checkpoint inhibitors by Dall’Olio, Filippo G., Marabelle, Aurélien, Caramella, Caroline, Garcia, Camilo, Aldea, Mihaela, Chaput, Nathalie, Robert, Caroline, Besse, Benjamin

“…Accumulating evidence suggests that a high tumour burden has a negative effect on anticancer immunity. The concept of tumour burden, simply defined as the…”
Get full text

Clinical and demographic factors associated to the place of death in advanced cancer patients assisted at home in Italy by Varani, Silvia, Dall'Olio, Filippo G, Messana, Rossana, Tanneberger, Stephan, Pannuti, Raffaella, Pannuti, Franco, Biasco, Guido

“…Introduction Studies on the end of life have shown that patients with advanced cancer prefer to die at home, and their caregivers agree with this choice…”
Get full text

Baseline total metabolic tumour volume on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography-computed tomography as a promising biomarker in patients with advanced non–small cell lung cancer treated with first-line pembrolizumab by Dall’Olio, Filippo G., Calabrò, Diletta, Conci, Nicole, Argalia, Giulia, Marchese, Paola Valeria, Fabbri, Francesca, Fragomeno, Benedetta, Ricci, Dalia, Fanti, Stefano, Ambrosini, Valentina, Ardizzoni, Andrea

“…Immune checkpoint inhibitors (ICIs) have become the standard of care in the management of advanced non–small cell lung cancer (NSCLC). Nevertheless, only a…”
Get full text

PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors by Dall'Olio, Filippo G., Gelsomino, Francesco, Conci, Nicole, Marcolin, Laura, De Giglio, Andrea, Grilli, Giada, Sperandi, Francesca, Fontana, Francesca, Terracciano, Mario, Fragomeno, Benedetta, Tober, Nastassja, Manferrari, Giulia, Brocchi, Stefano, Golfieri, Rita, Fiorentino, Michelangelo, Ardizzoni, Andrea

“…Circulating tumor cells (CTCs) are a promising source of biological information in cancer. Data correlating PD-L1 expression in CTCs with patients’ response to…”
Get full text

Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients – A single centre experience by Dall’Olio, Filippo G., Conci, Nicole, Rossi, Giulio, Fiorentino, Michelangelo, De Giglio, Andrea, Grilli, Giada, Altimari, Annalisa, Gruppioni, Elisa, Filippini, Daria M., Di Federico, Alessandro, Nuvola, Giacomo, Ardizzoni, Andrea

“…•Molecular diagnosis determines treatment for advanced lung adenocarcinoma.•Molecular alterations can be assessed singularly or together within single NGS…”
Get full text

Principles of medical and oncological management of giant masses of the mediastinum: a narrative review by Conci, Nicole, Grilli, Giada, Dall'Olio, Filippo G

“…Giant mediastinal tumors are represented by well-defined histological variants originating from different structures and compartments while their clinical…”
Get full text

The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma-Letter by Di Federico, Alessandro, Filippini, Daria M, Dall'Olio, Filippo G, Conci, Nicole, Minari, Roberta, Tiseo, Marcello, Ardizzoni, Andrea

Get full text

CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors by Dall’Olio, Filippo G., Abbati, Francesca, Facchinetti, Francesco, Massucci, Maria, Melotti, Barbara, Squadrilli, Anna, Buti, Sebastiano, Formica, Francesca, Tiseo, Marcello, Ardizzoni, Andrea

“…Aims: To assess prognostic value of pre-therapy carcinoembryonic antigen (CEA) and cytokeratin-19 fragments (CYFRA 21-1) blood levels in non-small cell lung…”
Get full text

Metabolic tumor volume assessed by 18F FDG - PET CT scan as a predictive biomarker for immune checkpoint blockers in advanced NSCLC and its biological correlates by Dall'Olio, Filippo G, Zrafi, Wael, Roelants, Veronique, Ambrosini, Valentina, Fourquet, Aloyse, Mitea, Cristina, Passiglia, Francesco, Bauckneht, Matteo, Bonardel, Gerald, Conci, Nicole, Benitez, Jose Carlos, Arena, Vincenzo, Namour, Céline, Naigeon, Marie, Monnet, Isabelle, Beshiri, Kristi, Hoton, Delphine, Dursun, Safiye, Danlos, Francois Xavier, Argalia, Giulia, Aldea, Mihaela, Rovera, Guido, Derosa, Lisa, Iebba, Valerio, Gietema, Hester A, Gounant, Valerie, Lacroix, Valérie, Remon, Jordi, Gautheret, Daniel, Chaput, Nathalie, Job, Bastien, Kannouche, Patricia L, Velasco-Nuño, Monica, Zitvogel, Laurence, Cella, Eugenia, Chícharo de Freitas, José Reinaldo, Vasseur, Damien, Bettaieb, Mohamed Aymen, Tagliamento, Marco, Hendriks, Lizza, Italiano, Antoine, Planchard, David, Marabelle, Aurelien, Barlesi, Fabrice, Novello, Silvia, De Andreis, Desiree, Aboubakar Nan, Frank, Ardizzoni, Andrea, Zalcman, Gerard, Garcia, Camilo, Besse, Benjamin

“…This study aimed to explore metabolic tumor volume (tMTV) as assessed 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG-PET/CT),…”
Get full text

The ‘surprise’ question in advanced cancer patients: A prospective study among general practitioners by Moroni, Matteo, Zocchi, Donato, Bolognesi, Deborah, Abernethy, Amy, Rondelli, Roberto, Savorani, Giandomenico, Salera, Marcello, Dall’Olio, Filippo G, Galli, Giulia, Biasco, Guido, Balduzzi, Antonio, Bandi, Giulio, Baraldini, Laura, Bauleo, Salvatore, Bertini, Luigi, Borghi, Paolo, Calzoni, Paolo, Camanzi, Maurizio, Cammarata, Antonino, Casarini, Piero, Cau, Roberto, Deni, Cecilia, Ehrlich, Shirley, Ermini, Giuliano, Franco, Livio, Furlò, Giancarlo, Grandi, Marina, Luigi Lalli, Antonio, Maccaferri, Marco, Marzo, Carla, Masi, Angelo, Matrà, Annunzio, Mazzetti Gaito, Piero, Montanari, Federico, Oggianu, Massimo, Ognibene, Gianluca, Palasciano, Maria, Palestini, Saida, Perrone, Fernando, Quadrelli, Stefano, Rappacciolo, Antonino, Rubini, Stefano, Salera, Marcello, Santi, Sandra, Savorani, Giandomenico, Serio, Alberto, Maria Severino, Anna, Siena, Matteo, Speziali, Pietro, Spinnato, Luigi, Tosetti, Cesare, Velonà, Pietro, Verri, Andrea, Zocchi, Donato

“…Background: Using the ‘surprise’ question ‘Would you be surprised if this patient died in the next year?’ may improve physicians’ prognostic accuracy and…”
Get full text

Monitoring tumor growth rate to predict immune checkpoint inhibitors’ treatment outcome in advanced NSCLC by Dall’Olio, Filippo G., Parisi, Claudia, Marcolin, Laura, Brocchi, Stefano, Caramella, Caroline, Conci, Nicole, Carpani, Giulia, Gelsomino, Francesco, Ardizzoni, Stefano, Marchese, Paola Valeria, Paccapelo, Alexandro, Grilli, Giada, Golfieri, Rita, Besse, Benjamin, Ardizzoni, Andrea

“…Introduction: Radiological response assessment to immune checkpoint inhibitor is challenging due to atypical pattern of response and commonly used RECIST 1.1…”
Get full text

Immortal time bias in the association between toxicity and response for immune checkpoint inhibitors: A systematic review and meta-analysis by Dall'Olio, Filippo G., Rizzo, Alessandro, Mollica, Veronica, Massucci, Maria, Maggio, Ilaria, Massari, Francesco

“…Abstract only e15080 Background: A number of studies have addressed the association between Immune related Adverse Events (IrAE) and outcome in patients…”
Get full text

Overcoming Primary Resistance to PD-1 Inhibitor With Anti-PD-L1 Agent in Squamous-Cell NSCLC: Case Report by Gelsomino, Francesco, Di Federico, Alessandro, Filippini, Daria M, Dall'Olio, Filippo G, Lamberti, Giuseppe, Sperandi, Francesca, Balacchi, Caterina, Brocchi, Stefano, Ardizzoni, Andrea

Get full text